Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 680 across all filing types
Latest filing 2022-03-21 Proxy Solicitation & In…
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Gland Pharma Limited, dated March 21, 2022. It is a formal notice to shareholders regarding resolutions to be passed through remote e-voting, including re-appointment of the Managing Director & CEO and appointment of a new director. The document references compliance with the Companies Act, SEBI regulations, and MCA circulars. It is a notice for shareholders to vote on specific corporate governance matters and does not contain financial statements or results. It is not a report or announcement of voting results but the notice itself for the postal ballot process. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2022-03-21 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement for the registration of e-mail addresses of members. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 47, which pertains to public notices and disclosures. The document does not contain financial data, management discussion, voting results, or any report content. It is essentially an announcement of a published advertisement for regulatory compliance purposes. The document length is short (1382 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-03-16 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure of material events and information. The content is a schedule of upcoming meetings with investors and analysts, not a financial report or earnings release. It is an update on investor relations activities rather than a presentation or transcript. Therefore, it fits best under Investor Presentation (IP) as it relates to investor engagement and communication, but since it is only a schedule notice and not a detailed presentation, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain financial data or detailed presentation content. The document length is short and it is an announcement of meetings, not a report or transcript. Hence, the classification is Regulatory Filings (RNS).
2022-03-11 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a board meeting. It details appointments and resignations of directors, including re-appointment of the Managing Director and CEO, appointment of an additional director, and resignation of a director. It includes annexures with detailed profiles of the directors. The document references compliance with SEBI regulations and provides disclosures pursuant to SEBI circulars. There is no financial data, earnings information, or report publication mentioned. The primary content is about changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length (8938 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-03-10 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting. It details the appointment and resignation of directors, including re-appointment of the Managing Director and CEO, appointment of an additional director, and resignation of another director. It includes annexures with detailed profiles of the directors. The document references compliance with SEBI regulations and provides disclosures pursuant to SEBI circulars. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on changes in the company's board of directors and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length (8938 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-03-10 English
Re-appointment
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a board meeting. It details the appointment and resignation of directors, including re-appointment of the Managing Director and CEO, appointment of an additional director, and resignation of another director. It includes annexures with detailed profiles of the appointed directors. The document references compliance with SEBI regulations related to listing obligations and disclosure requirements. There is no financial data, earnings information, or report publication mentioned. The primary content is about changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length (8938 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-03-10 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.